Navigation Links
Chindex International to Report First Quarter 2011 Financial Results
Date:8/2/2010

BETHESDA, Md., Aug. 2 /PRNewswire-Asia/ -- Chindex International, Inc. ("Chindex") (Nasdaq: CHDX), a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced that the Company plans to release first quarter fiscal 2011 financial results on Monday, August 9, 2010, before the market opens. Management will host a conference call at 8:00 am ET that day to discuss financial results.

To participate in the conference call, U.S. domestic callers may dial 1-877-303-9231 and international callers may dial 1-760-666-3567 approximately 10 minutes before the conference call is scheduled to begin. A telephone replay will be available from the day of the call until August 16, 2010, by dialing (U.S. domestic) 1-800-642-1687 or (international) 1-706-645-9291, passcode 91894764. A webcast of the earnings call will be accessible via Chindex's website at http://ir.chindex.com/events.cfm .

About Chindex International, Inc.

Chindex is an American health care company that provides health care services and supplies medical capital equipment, instrumentation and products to the Chinese marketplace, including Hong Kong. Health care services are provided through the operations of its United Family Healthcare division, a network of private primary care hospitals and affiliated ambulatory clinics in China. The Company's hospital network currently operates in Beijing, Shanghai and Guangzhou. Chindex sells medical products manufactured by various major multinational companies, including Siemens AG and Intuitive Surgical, for which the Company is the exclusive distribution partner for the sale and servicing of color ultrasound systems and surgical robotic systems respectively. It also arranges financing packages for the supply of medical products to hospitals in China utilizing the export loan and loan guarantee programs of both the U.S. Export-Import Bank and the German KfW Development Bank. With twenty-eight years of experience, approximately 1,300 employees, and operations in China, Hong Kong, the United States and Germany, the Company's strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's website, http://www.chindex.com .

    For more information, please contact:

    Integrated Corporate Relations
     Ashley M. Ammon
     Tel: +1-646-277-1227


'/>"/>
SOURCE Chindex International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results
2. Chindex International to Report Third Quarter Fiscal Year 2010 Financial Results
3. Chindex International to Present at Piper Jaffray Health Care Conference
4. Chindex International Announces Participation in Brean Murray, Carret & Co. 2009 China Growth Conference
5. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
6. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
7. Robert F. Walters Appointed Chairman of the Board of Directors of ORBIS International
8. Airline Passenger Experience Association Teams Up With ORBIS International in Their Fight Against Avoidable Blindness
9. Update: International HIV/AIDS Partnership Wins Two Awards for Supply Chain Excellence
10. New Edition of Guidelines for Involving Communities in HIV Prevention Research Released at International AIDS Conference
11. SRI International and Stanford University School of Medicines MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... LONDON , Dec. 6, 2016 Diabetes ... The diabetes and obesity disease cluster is currently ... (T1DM) and type 2 diabetes mellitus (T2DM), and the ... and quality of products, is attributable to these indications. ... a large market presence, there are a large number ...
(Date:12/6/2016)... The pen needles market is projected to ... billion in 2016, growing at a CAGR of 11.2% ... Over the years, the pen needles market has witnessed ... growing demand for safety injections in the healthcare industry. ... pen needles with an aim to reduce pain, increase ...
(Date:12/6/2016)... Eurofins Genomics today announced it has ... American Pathologists (CAP) and certification under the Clinical ... in Louisville, KY , where ... "Our new CLIA-licensed and CAP-accredited clinical ... considered the ,Gold Standard, method for validation of ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and ... The Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® Products Now ... the Phoenix Valley with Delightful Deals on Botox® and Juvederm® just in ...
(Date:12/7/2016)... ... , ... "ProBrand Flip allows FCPX editors to create unique logo reveals which ... Pixel Film Studios. , ProBrand Flip includes 30 flip book reveal animations. Easily reveal ... a variety of flip book animations. In Addition, users can modify each preset to ...
(Date:12/7/2016)... ... December 07, 2016 , ... “The Road To Restoration”: an informative ... a one hour a week showing of hands. “The Road To Restoration” is the ... you are familiar with the brass ring that you could reach out for, and ...
(Date:12/7/2016)... (Dec. 3, 2016) , ... (PRWEB) December 07, ... ... only patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, was awarded ... New Mexico with a patient engagement program. New Mexico has more people with ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Hacking into my medical record ... him as 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in the ... Wyston Books, Inc. These novels narrate the lives of a poor teenager ...
Breaking Medicine News(10 mins):